The phantom study showed that phantom position was linearly correlated with the exit detector measurements resulting in an r > 0.99. The standard deviation in the measured breast surface position, σ, was 2.28 mm for the 453 analyzed detector fluences (σmin = 1.39 mm, σmax = 4.33 mm). The uncertainty in the detector measurements was estimated to be under one detector channel's width.
Conclusion:
The σ results of this study should be an indicator of the overall positioning uncertainty in our IGRT process for these treatments, i.e. kVCT-MVCT image registration, patient movement, and respiratory motion. Even if only one projection of the treatment data was used in the estimation, our results compare very well with similar studies ' (von Tienhoven et al (1991) , Smith et al (2005) , Wang et al (2013)) findings on breast displacement due to respiratory motion. Furthermore, the novelty of this study is its evaluation of the breast position was performed on exit detector fluence of intensity-modulated fields, which we believe to be a first. Purpose or Objective: A a real-time patient treatment verification system using EPID (Watchdog) for clinical implementation was developed as an advanced patient safety tool. However to use Watchdog for treatment intervention we need to understand its response to clinically significant errors. The purpose of this study is to investigate the performance of Watchdog under controlled error conditions.
OC-0361 Simulation of clinical relevance errors detected by realtime EPID-based patient verification system

Material and Methods:
The real-time verification system (Watchdog) utilises a comprehensive physics-based model to generate a series of predicted transit cine EPID image as a reference data set, and compares these to measured cine-EPID images acquired during treatment. The agreement between the predicted and measured transit images is quantified using chi-comparison on a cumulative frame basis.
To determine the ability of Watchdog to detect clinically significant errors during treatment delivery we used real patient data and simulated dosimetric and patient positional errors. Four study cases were used; dosimetric error in Prostate IMRT, HN patient weight loss, prostate displacement and lung SBRT displacement errors. These errors were introduced by modifying the planning CT scan data and re-calculating the predicted EPID data set. The error embedded predicted EPID data sets were compared to the measured EPID data acquired during patient treatment.
Results:
The average % cumulative chi pass-rate across four case studies were 84.0% and 94.5% for 3%, 3mm and 4%, 4mm respectively. In the figures, the cumulative chi pass-rate results based on error simulation are shown. The difference ratio of chi comparison criteria between 3%, 3mm and 4%, 4mm was approximately 13%. As a result, the threshold level should determine based on the criteria and clinical acceptant limit.
Conclusion:
We have evaluated our proposed real-time EPIDbased treatment verification system using clinical relevant error simulation in prostate, HN and lung cases. Using either a 3%, 3mm or 4%, 4mm criteria, the real-time EPID-based patient verification system successfully detected simulated errors introduced into patient plan deliveries; including 5% dosimetric errors on prostate IMRT, 5mm prostate IMRT displacement, 5% HN patient weight loss, and 5mm Lung SBRT displacement. Purpose or Objective: The increasing complexity of modern radiation therapy requires major quality control (QC) to ensure safety and reliability of patients' treatments. The large number of QCs requires a considerable amount of work that sometime is responsible of missing controls that may lead to dosimetric errors. In this frame the in vivo dosimetry (IVD) by EPID images has an important role to detect eventual dosimetric discrepancies between planned and delivered doses. The present work reports the results of 7500 IVD tests obtained in the last 2 years in 7 Italian Centers.
OC-0362 EPID-based in-vivo dosimetry results: a national statistic
Material and Methods:
SOFTDISO is an IVD-program distributed by the Best Medical Italy for 3D-CRT ,IMRT and
